IntelGenx Technologies Corp. Forms Strategic Agreement with Azur Pharma to Develop Prenatal Vitamin Supplements Addressing a U.S. Market of $250 Million

SAINT LAURENT, QUEBEC--(Marketwire - January 07, 2008) - IntelGenx Corp. (OTCBB: IGXT) ("IntelGenx" or the "Company") has formed a strategic agreement with Azur Pharma to develop and commercialize prenatal vitamin supplements using IntelGenx's proprietary oral delivery technology.
MORE ON THIS TOPIC